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Background: The aim of this study was to prospectively examine echocardiographic parameters that correlate and
predict functional capacity assessed by 6 min walk test (6-MWT) in patients with heart failure (HF), irrespective of
ejection fraction (EF).
Methods: In 147 HF patients (mean age 61 ± 11 years, 50.3% male), a 6-MWT and an echo-Doppler study were
performed in the same day. Global LV dyssynchrony was indirectly assessed by total isovolumic time - t-IVT [in
s/min; calculated as: 60 – (total ejection time+ total filling time)], and Tei index (t-IVT/ejection time). Patients were
divided into two groups based on the 6-MWT distance (Group I: ≤300 m and Group II: >300 m), and also in two
groups according to EF (Group A: LVEF≥ 45% and Group B: LVEF < 45%).
Results: In the cohort of patients as a whole, the 6-MWT correlated with t-IVT (r =−0.49, p < 0.001) and Tei index
(r =−0.43, p < 0.001) but not with any of the other clinical or echocardiographic parameters. Group I had lower
hemoglobin level (p = 0.02), lower EF (p = 0.003), larger left atrium (p = 0.02), thicker interventricular septum
(p = 0.02), lower A wave (p = 0.01) and lateral wall late diastolic myocardial velocity a’ (p = 0.047), longer isovolumic
relaxation time (r = 0.003) and longer t-IVT (p = 0.03), compared with Group II. In the patients cohort as a whole,
only t-IVT ratio [1.257 (1.071-1.476), p = 0.005], LV EF [0.947 (0.903-0.993), p = 0.02], and E/A ratio [0.553 (0.315-0.972),
p = 0.04] independently predicted poor 6-MWT performance (<300 m) in multivariate analysis. None of the
echocardiographic measurements predicted exercise tolerance in HFpEF.
Conclusion: In patients with HF, the limited exercise capacity, assessed by 6-MWT, is related mostly to severity of
global LV dyssynchrony, more than EF or raised filling pressures. The lack of exercise predictors in HFpEF reflects its
multifactorial pathophysiology.
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Heart failure (HF) has become a major public health prob-
lem [1], and its incidence is increasing [2], particularly that
caused by systolic left ventricular (LV) dysfunction, which
is known to have poor prognosis [3,4]. In patients with sys-
tolic HF, systolic [5] and diastolic [6,7] LV velocity para-
meters, as well as right ventricular [8] function have been
shown to correlate with functional capacity. However,
detailed assessment of cardiac function timing [9] has
shown that similar clinical limitation could be seen in
patients with isolated diastolic myocardial abnormalities in
the presence of preserved LV ejection fraction (EF)
(HFpEF) [10]. Irrespective of EF, the morbidity and mortal-
ity of patients with HF remain high, despite advances in
pharmacological and non-pharmacological treatments
[11,12], suggesting a need for identifying other functional
parameters that guide towards optimum management and
better clinical outcome.
Ventricular dyssynchrony has been shown to contrib-
ute to clinical deterioration of HF and resynchronization
therapy has proved the opposite [13-15]. LV segmental
and global dyssynchrony can easily be assessed by Dop-
pler echocardiography [16-18], with its parameters not
only predicting prognosis but also the extent of exercise
tolerance. Six-minute walk test (6-MWT) is very popular
for objective assessment of exercise capacity in HF [19],
particularly in secondary and tertiary referral centers
[20,21]. We have previously shown that echocardio-
graphic markers of raised left atrial pressure and those
of ventricular dyssynchrony predict limited exercise cap-
acity in patients with poor LV EF [22]. However, the pre-
dictive role of echocardiography in assessing limited
exercise capacity in patients with HFpEF has not been
thoroughly investigated. The aim of this study was to
prospectively examine predictors of functional capacity,
assessed by 6-MWT in a consecutive group of patients
irrespective of EF. This objective is based on the ration-
ale that HFpEF patients have multi-factorial causes for
limited exercise capacity therefore difficult to identify




We studied 147 patients (mean age 61 ± 11 years, 50.3%
male) with clinical diagnosis of congestive heart failure,
and New York Heart Association (NYHA) functional
class I-III, secondary to ischemic heart disease or non-
ischemic etiology. Patients were referred to the Service
of Cardiology, Internal Medicine Clinic, University Clin-
ical Centre of Kosovo, between December 2005 and
April 2011. At the time of the study all patients were on
optimum cardiac medications, optimized at least 2 weeks
prior to enrollment, based on patient’s symptoms andrenal function: 81% were receiving ACE inhibitors or
ARB, 70% beta-blockers, 11% digoxin, 46% spironolac-
tone, 64% diuretics. Patients with reduced LV EF had is-
chemic etiology in 42%, hypertensive in 25%, and
unknown etiology in 33%. Patients with preserved LV EF
had ischemic aetiology in 44% and hypertensive in 56%.
All patients were in sinus rhythm. Fifty seven patients
had LV EF <45% (HFpEF), and the remaining 90 patients
had LV EF ≥45% (Table 1). Patients with clinical evi-
dence for cardiac decompensation, limited physical ac-
tivity due to factors other than cardiac symptoms (e.g.
arthritis), more than mild mitral regurgitation, more
than mild renal failure, chronic obstructive pulmonary
disease (COPD) or those with recent acute coronary
syndrome, stroke or anemia were excluded. Patients gave
a written informed consent to participate in the study,
which was approved by the local Ethics Committee.
Data collection
Detailed history and clinical assessment were obtained
in all patients, in whom routine biochemical tests were
also performed including hemoglobin, lipid profile,
blood glucose level, and kidney function tests. Estimated
body mass index (BMI) was calculated from weight and
height measurements. Waist, hip measurements were
also made and waist/hip ratio calculated.
Echocardiographic examination
A single operator performed all echocardiographic
examinations using a Philips Intelligent E-33 system
with a multi-frequency transducer, and harmonic im-
aging as appropriate. Images were obtained with the pa-
tient in the left lateral decubitus position and during
quiet expiration. End-systole and end-diastole LV
dimensions were made from the left parasternal long
axis view with the M-mode cursor positioned by the tips
of the mitral valve leaflets. LV volumes and EF were cal-
culated from the apical 2 and 4 chamber views using the
modified Simpson’s method. Ventricular long axis mo-
tion was studied by placing the M-mode cursor at the
lateral and septal angles of the mitral ring and the lateral
angle of the tricuspid ring. Total amplitude of long axis
motion was measured as previously described [23] from
peak inward to peak outward points. LV and right ven-
tricular (RV) long axis myocardial velocities were also
studied using Doppler myocardial imaging technique.
From the apical 4-chamber view, longitudinal velocities
were recorded with the sample volume placed at the
basal part of LV lateral and septal segments as well as
RV free wall. Systolic (s’), as well as early and late (e’ and
a’) diastolic myocardial velocities were measured with
the gain optimally adjusted. Mean value of the lateral
and septal LV velocities were calculated. Left atrial diam-
eter was measured from aortic root recordings with the
Table 1 Comparison of echocardiographic data between
patient’s groups
Variable Limited performance Good performance P
(n = 90) (n =57)
Systolic LV function
Ejection fraction (%) 34 ± 12 41 ± 15 0.003
Interventricular
septum (cm)
1.06 ± 0.1 1.11 ± 0.2 0.07
Left atrium (cm) 4.8 ± 0.7 4.5 ± 0.7 0.02
LV EDD (cm) 6.4 ± 1.3 6.1 ± 1.1 0.15
LV ESD (cm) 5.3 ± 1.0 4.9 ± 1.1 0.08
Septal long axis
amplitude (cm)
0.8 ± 0.3 0.9 ± 0.3 0.21
Septal s’ wave (cm/s) 6.3 ± 1.4 7 ± 2.6 0.24
Lateral long axis
amplitude (cm)
.05 ± 0.3 1.1 ± 0.3 0.24
Lateral s’ wave (cm/s) 6.1 ± 2.4 6.5 ± 2.5 0.51
LV posterior wall (cm) 1.0 ± 0.1 1.0 ± 0.4 0.86
Aortic root (cm) 3.4 ± 0.3 3.4 ± 0.4 0.94
Diastolic LV function
A wave velocity (cm/s) 58 ± 21 72 ± 29 0.009
Lateral a’ wave (cm/s) 7 ± 2.5 8.3 ± 3.5 0.047
E wave deceleration
time (ms)
146 ± 57 168± 65 0.08
Lateral e’ wave (cm/s) 6 ± 2.3 6.4 ± 2 0.28
E/A ratio 1.2 ± 0.8 1.6 ± 1.1 0.045
Septal a’ wave (cm/s) 8.2 ± 2.5 8.7 ± 5 0.64
Septal e’ wave (cm/s) 6 ± 2.2 6 ± 2.8 0.71
E wave velocity (cm/s) 69 ± 24 70 ± 32 0.75
Left atrial area 27 ± 8.2 28 ± 8.6 0.88
Global LV function
T-IVT 14.1 ± 3.8 11.8 ± 4.4 0.03
Tei index 0.74 ± 0.5 0.6 ± 0.3 0.07
IVRT 121 ± 35 99 ± 24 0.003
E/e’ ratio 12.6 ± 6.6 11.6 ± 5.6 0.41
RV function
A wave velocity (cm/s) 51 ± 15 54 ± 22 0.44
E wave deceleration
time (ms)
154 ± 68 157± 71 0.84
Right long axis
amplitude (cm)
2 ± 0.61 2 ± 0.6 0.93
PSAP (mmHg) 44.3 ± 23 44.4 ± 17 0.99
Right e’ wave (cm/s) 9.7 ± 4.3 9 ± 3.8 0.57
Right a’ wave (cm/s) 15 ± 5.6 13 ± 4.7 0.24
Right s’ wave (cm/s) 10.6 ± 2.9 11.2 ± 3.2 0.52
EDD (cm) 3.2 ± 0.9 2.8 ± 0.6 0.06
LV left ventricle, RV right ventricle, A atrial diastolic velocity, E early diastolic filling
velocity, EDD end-diastolic dimension, ESD end-systolic dimension, T-IVT total
isovolumic time, IVRT isovolumic relaxation time, s’ systolic myocardial velocity,
e’ early diastolic myocardial velocity, a’ late diastolic myocardial velocity.
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Diastolic function of the LV and RV was assessed from
filling velocities using spectral pulsed wave Doppler with
the sample volume positioned at the tips of the mitral
and tricuspid valve leaflets, respectively, during a brief
apnea. Peak LV and RV early (E wave), and late (A wave)
diastolic velocities were measured and E/A ratios were
calculated. The E/e’ ratio was calculated from the trans-
mitral E wave and the mean lateral and septal segments
e’ waves. The isovolumic relaxation time was also mea-
sured from aortic valve closure to mitral valve opening,
on the pulsed wave Doppler recording. LV filling pattern
was considered ‘restrictive’ when E/A ratio was >2.0, E
wave deceleration time < 140 ms and the left atrium
dilated of more than 40 mm in transverse diameter [24].
Measurements of LV dyssynchrony
Indirect assessment of LV dyssynchrony was obtained by
measuring total isovolumic time (t-IVT), Tei Index and
LV-RV pre-ejection time delay. Total LV filling time was
measured from the onset of the E wave to the end of the
A wave and ejection time from the onset to the end of
the aortic Doppler flow velocity. Total isovolumic time
(t-IVT) was calculated as 60 - (total ejection time + total
filling time) and was expressed in s/min [25]. Tei index
was calculated as the ratio between t-IVT and ejection
time [26]. LV and RV pre-ejection times were measured
as the time interval between the onset of the q wave and
the onset of the aortic and pulmonary forward flow vel-
ocities, respectively and the time delay between them
was calculated [26].
Mitral regurgitation severity was assessed by color and
continuous wave Doppler and was graded as mild, mod-
erate, or severe according to the relative jet area to that
of the left atrium as well as the flow velocity profile, in
line with the recommendations of the American Society
of Echocardiography [27]. Likewise, tricuspid regurgita-
tion was assessed by color Doppler and continuous-
wave Doppler. Retrograde trans-tricuspid pressure
drop > 35 mmHg was taken as an evidence for pul-
monary hypertension [28]. All M-mode and Doppler
recordings were made at a fast speed of 100 mm/s
with a superimposed ECG (lead II).
Six minute walk test
Within 24 h of the echocardiographic examination a 6-
MWT was performed on a level hallway surface for all
patients and was administered by a specialized nurse
blinded to the results of the echocardiogram. According
to the method of Gyatt et al. [29] patients were informed
of the purpose and protocol of the 6 MWT which was
conducted in a standardized fashion while patients on
their regular medications [30,31]. A 15 m flat, obstacle-
Figure 1 Correlation between total isovolumic time and 6 min
walk distance in patients with heart failure.
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walk as far as they can, turning 180° after they have
reached the end of the corridor, during the allocated
time of 6 min. Patients walked unaccompanied so as not
to influence walking speed. At the end of the 6 min the
supervising nurse measured the total distance walked by
the patient. Pulse and blood pressure were measured be-
fore and at the end of the walking test.
Statistical analysis
Data are presented as mean ± SD or proportions (% of
patients). Continuous data was compared with two-
tailed unpaired Student’s t test and discrete data with
Chi-square test. Correlations were tested with Pearson
coefficients. Predictors of 6 MWT distance were identi-
fied with univariate analysis and multivariate logistic re-
gression was performed using the step-wise method, a
significant difference was defined as P < 0.05 (2-tailed).
Patients were divided according to their ability to walk
>300 m into good and limited exercise performance
groups [32], and were compared using unpaired Student
t-test. Also, patients with maintained HFpEF were com-
pared with those with reduced EF (<45%) using unpaired
t-test.
Results
Patients mean age was 61 ± 11 years, and 50.3% were
females (Table 2). The etiology of heart failure was is-
chemic in 68 patients (46%), idiopathic in 44 (30%) and
hypertensive in 35 (24%) patients. The studied patients
as a whole exercised for a mean of 265 ± 111 m and had
to stop because of breathlessness and/or tiredness.
Patients with HF and reduced EF exercised for 241 ± 107Table 2 Baseline patient’s data in study patients
Sex (female, in%) 49.7




Body-mass index 28 ± 5
Waist/hips ratio 0.95 ± 0.1
NYHA class 2.3 ± 0.6
Fasting glucose (mmol/L) 7 ± 3.3
Total cholesterol (mmol/L) 4.3 ± 1.3
Triglycerides (mmol/L) 1.7 ± 1
Urea (mmol/L) 9.9 ± 4.5
Creatinine (μmol/L) 109± 41
Hemoglobine (g/L) 128± 23
Heart rate (beats/min) 78 ± 13
Data are mean ± standard deviation. NYHA = New York Heart Association.m compared to 275 ± 112 m in those with HFpEF,
(p = 0.09).Clinical and echocardiographic correlates of 6 MWT
distance
Out of the list of Doppler echocardiographic measure-
ments, only markers of global dyssynchrony, t-IVT
(r =−0.49, p < 0.001) and Tei index (r =−0.43, p < 0.001)
correlated with the 6-MWT distance using Pearson’s
correlation model (Figure 1 & 2).Patients with limited vs. good 6 MWT performance
Hemoglobin (p = 0.03) and smoking (p = 0.04) were the
only clinical finding that was different between the two
groups of patients with good and limited exercise per-
formance (Table 3). Patients with limited 6-MWT per-
formance had lower EF (p = 0.003), larger left atrium
(p = 0.02), lower A wave (p = 0.009) and lateral myocar-
dial velocity a’ (p = 0.047), but longer isovolumic relax-
ation time (p = 0.003) and longer t-IVT (p = 0.03,
Table 1).Figure 2 Correlation between Tei index and 6 min walk
distance in patients with heart failure.
Table 3 Comparison of clinical and biochemical data
between patient’s groups
Variable Limited performance Good performance P value
(n = 90) (n =57)
Sex (female, in%) 53 43 0.26
Age (years) 61 ± 12 61 ± 10 0.81
Smoking (%) 25 44 0.04
Diabetes (%) 34 30 0.67
LBBB (%) 24 26 0.75
Preserved EF (%) 30 40 0.24
Body-mass index 28 ± 5 28± 4 0.91
Waist/hips ratio 0.95 ± 0.1 0.97 ± 0.1 0.28
NYHA class 2.3 ± 0.6 2.5 ± 0.7 0.09
Fasting glucose
(mmol/L)
6.9 ± 3.3 7.1 ± 2.7 0.84
Total cholesterol
(mmol/L)
4.2 ± 1.2 4.3 ± 1.3 0.16
Triglycerides
(mmol/L)
1.8 ± 1.2 1.6 ± 0.4 0.25
Urea (mmol/L) 9.9 ± 4.3 9.5 ± 5.2 0.66
Creatinine
(μmol/L)
111 ± 36 108 ± 55 0.74
Haemoglobine
(g/L)
123 ± 28 133 ± 16 0.03
Heart rate
(beats/min)
79 ± 13 77 ± 14 0.51
Data are mean ± standard deviation. NYHA = New York Heart Association.
Table 4 Predictors of limited 6 min walk test
Variable Odds ratio (95% CI) P value (<)
Clinical univariate predictors
Hemoglobin 1.020 (1.000-1.041) 0.047
Heart rate 1.027 (0.999-1.056) 0.06
NYHA class 1.535 (0.878-2.685) 0.13
Gender 1.502 (0.734-3.073) 0.27
Creatinine 1.003 (0.995-1.012) 0.47
Urea 1.030 (0.950-1.117) 0.47
Body-mass index 1.028 (0.947-1.117) 0.51
Diabetes mellitus 0.847 (0.394-1.820) 0.67
Age 1.004 (0.973-1.036) 0.81
Echocardiographic univariate predictors
T-IVT 0.743 (0.646-0.855) <0.001
Tei index 0.038 (0.007-0.219) <0.001
IVRT 0.974 (0.957-0.992) 0.005
LV EF 1.049 (1.013-1.087) 0.007
E/A ratio 1.526 (1.035-2.251) 0.03
LV EDD 0.714 (0.483-1.055) 0.09
Right long axis amplitude 1.832 (0.885-3.791) 0.11
LV ESD 0.781 (0.562-1.086) 0.14
Left atrium 1.272 (0.763-2.120) 0.36
E wave deceleration time 0.997 (0.991-1.003) 0.39
E/e’ ratio 1.036 (0.943-1.140) 0.46
Lateral long axis amplitude 0.708 (0.197-2.554) 0.59
Septal long axis amplitude 0.794 (0.857-3.404) 0.76
Multivariate predictors
T-IVT 1.257 (1.071-1.476) 0.005
LV Ejection Fraction 0.947 (0.903-0.993) 0.02
E/A ratio 0.553 (0.315-0.972) 0.04
Haemoglobin 0.974 (0.947-1.001) 0.06
Gender 0.535 (0.188-1.523) 0.24
Age 1.022 (0.975-1.072) 0.37
LV left ventricle, A atrial diastolic velocity, E early diastolic filling velocity, EDD
end-diastolic dimension, ESD end-systolic dimension, T-IVT total isovolumic
time, IVRT isovolumic relaxation time, s’ systolic myocardial velocity, e’ early
diastolic myocardial velocity, a’ late diastolic myocardial velocity.
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Univariate predictors of limited 6 MWT distance
From the biochemical and clinical findings, only low
haemoglobin level (p = 0.047) predicted limited 6-MWT
distance. Prolonged t-IVT (p < 0.001), high Tei index
(p < 0.001), prolonged isovolumic relaxation time
(p = 0.005), low LV EF (p = 0.007) and high E/A ratio
(p = 0.03), were the echocardiographic predictors of lim-
ited distance (Table 4).
Multivariate predictors of limited 6 MWT distance
In multivariate analysis [odds ratio 95% confidence inter-
val], prolonged t-IVT [1.257 (1.071-1.476), p = 0.005],
low LV EF [0.947 (0.903-0.993), p = 0.02], and high E/A
ratio [0.553 (0.315-0.972), p = 0.04], independently pre-
dicted the limited 6-MWT distance (Table 4). A t-IVT
of 12.5 s/min had a sensitivity of 70% and specificity of
65% (AUC on ROC analysis of 73%) for predicting lim-
ited performance (Figure 3).
Patients with EF < 45% vs patients with HFpEF
We further divided the whole cohort into patients with
reduced EF (<45%) and those with HFpEF and compared
their clinical and echocardiographic parameters, as well
as exercise capacity and its predictors.Heart rate was the only clinical variable slightly lower
in patients with HFpEF compared to those with low EF
(p = 0.04). LV EDD, LV ESD and left atrium were all
smaller in HFpEF patients (p < 0.001, for all). Interventri-
cular septum was thicker (p = 0.01) and septal long axis
amplitude of motion (p = 0.049) were both higher in
HFpEF patients. LV filling A wave was higher (p = 0.002),
E wave deceleration time longer p = 0.03, and E/A
ratio lower (p = 0.008) in HFpEF patients (Table 1). None
of clinical or echocardiographic parameters inde-
pendently predicted the limited exercise in patients with
HFpEF.
Figure 3 ROC-curve of t-IVT in predicting poor exercise
performance on 6-min walk test in patients with heart failure.
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Findings
In this study we identified markers of global LV dyssyn-
chrony, measured by t-IVT and Tei index but not pre-
ejection time which correlated with the 6 MWT distance
in a group of patients with clinically stable HF irrespect-
ive of EF. A long t-IVT, a low LV EF and high trans-
mitral E/A ratio predicted limited exercise performance
in multivariate analysis. Low hemoglobin, a univariate
predictor, failed to independently predict limited exercise
performance. In a small subgroup of patients with
HFpEF none of the clinical parameters or functional
echocardiographic measurements predicted limited
6MWT distance.
Data interpretation
In the absence of musculoskeletal disorders, increased
body weight or chronic obstructive pulmonary disease,
limited exercise performance is commonly related to
cardiac dysfunction, in the form of reduced systolic
function (EF) or raised filling pressures [22,33]. These
two common findings have similar consequences, in the
form of raised pulmonary pressure, causing exertional
breathlessness. Our studied patients show this disturbed
pathophysiology, even partially, having shown reduced
LV EF and global LV dyssynchrony as independent pre-
dictors of limited exercise performance. Global dyssyn-
chrony in the form of prolonged t-IVT and high Tei
index restrict effective phases of the cardiac cycle,required for LV filling and ejection. This results in com-
promised stroke volume and consequently cardiac out-
put and exercise performance as previously shown [33].
In addition, limited left atrial emptying is bound to in-
crease pulmonary venous pressure and hence breathless-
ness [34] and limited exercise capacity. In individual
patients, a t-IVT cut off value of 12.5 s/m clearly discri-
minated good from limited exercise capacity, having
identified over 50% of patients. It must be mentioned
that normal exercise capacity is dictated by limited
stroke volume or raised left atrial pressure, based on
gender [35]. Theoretically therefore, correcting LV syn-
chronous function in heart failure patients by cardiac
resynchronisation therapy (CRT), in the absence of evi-
dence for a need for revascularization, is bound to re-
verse such disturbed physiology and cardiac symptoms
[36]. On the other hand when segregating the cohort
into patients with reduced EF and those with HFpEF
such predictive power of cardiac measurements for
6MWT distance was lost, suggesting the presence of
other mechanisms for breathlessness, even in a minority
of patients, which diluted the relationship we found
above. It also confirms the lack of uniformity of such
patients, currently combined under one diagnosis
‘HFpEF’ as has recently been shown not to respond to
one and the same medical protocol [37]. This finding
confirms our hypothesis stated in the introduction
above.
Limitations
We did not obtain Doppler echocardiographic measure-
ments at peak exercise, when patients became symptom-
atic, since the objective of the study was to simply
determine predictors of ordinary walking exercise limita-
tion rather than an exercise echocardiogram that should
have required a different protocol. We did not have in-
vasive measurements of left atrial pressures but relied on
Doppler measurements, which are known to be highly
reproducible and to closely correlate with invasive pres-
sure measurements [38]. We avoided using segmental
measurements of dyssynchrony, based on the recent
doubt of their accuracy [31]. We did not have BNP ant
NT-pro-BNP data in our patients. However, as the aim
of the study was the assessment of echocardiographic
predictors of exercise capacity in heart failure patients,
we believe that the lack of these data will not weaken
the results.
Clinical implications
Patients with HF, particularly those in NYHA class III
and IV are known to have significantly limited exercise
tolerance. Although EF is the most popular measure of
LV function, and is considered the corner stone for
recruiting patients for various treatment modalities,
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as part of the conventional protocol of the follow-up of
such patients. Despite exertional breathlessness in HF
patients is multi-factorial, identifying specific patterns of
cardiac dysfunction should guide towards optimum
management of individual patients, e.g. vasodilators in
patients with raised left atrial pressure and cardiac
resynchronisation therapy in those with ventricular dys-
synchrony, particularly when there is evidence for irre-
versible dyssynchrony. Those with HFpEF need
individualistic approach in assessing their exercise cap-
acity and management.
Conclusions
Patients with heart failure who appear to be clinically
stable may have significantly limited exercise ability. In
these patients, markers of global ventricular dyssyn-
chrony are as important, if not more, than markers of
systolic LV dysfunction, in predicting limited exercise
performance. Results of the small subgroup of patients
with HFpEF cannot be generalised without being tested
in a larger cohort.
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